High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes

Published:2011-06 Issue:6 Volume:35 Page:766-770
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Tang Guilin,Wang Sa A.,Menon Madhu,Dresser Karen,Woda Bruce A.,Hao Suyang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes;de Witte;Haematologica,2006

2. A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome;Fenaux;Blood,2007

3. Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients;Hamaki;Bone Marrow Transplant,2005

4. Treatment options in myelodysplastic syndromes: a new frontier;Santini;J Chemother,2008

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Molecular Characteristics of Megakaryocytes in Myelodysplastic Syndrome;Global Medical Genetics;2024-06

2. Romiplostim-associated increase in CD34+ megakaryocytes in a case of immune thrombocytopenia: A case report;Human Pathology Reports;2023-06

3. CD34-positive dwarf megakaryocytes in chronic myeloid leukemia are not indicators of disease progression;Indian Journal of Pathology and Microbiology;2023-04

4. References;Flow Cytometry of Hematological Malignancies;2021-04-06

5. CD34 and CD79a immunopositivity in megakaryocytes;Human Pathology: Case Reports;2021-03